Categories
Change Password!
Reset Password!
New international urticaria guideline advances bio...
Cetirizine among top performers for nasal symptoms...
A large network meta-analysis explored the efficacy and safety of oral H1-antihistamines in allergic rhinitis (AR) by synthesizing evidence from...
Canadian experts update guidance on allergic rhini...
A newly released Canadian-focused practice parameter is reshaping the clinical approach to allergic rhinitis (AR), emphasizing individualized tre...
ARIA survey highlights global variation in allergi...
Allergic rhinitis (AR) medications can vary substantially in both availability and affordability between countries and across different periods....
Remibrutinib in CSU: Findings from Phase 3 BISCUIT...
Remibrutinib, a highly selective oral Bruton’s tyrosine kinase (BTK) inhibitor, is emerging as a next-generation therapy for the management...
Rapid assessment of chronic spontaneous urticaria...
In chronic spontaneous urticaria (CSU), the weekly urticaria activity score (UAS) is widely used to evaluate disease activity from the patient...
Six-year safety evaluation of upadacitinib in mode...
Atopic dermatitis (AD) is marked by eczematous lesions, severe pruritus, and skin dryness that can hamper quality of life.
Proactive atopic dermatitis treatment lowers food...
Atopic dermatitis (AD) is frequently the earliest step in the “atopic march,” a sequence of allergic conditions that can progress to...
Breastfeeding for ≥4 months linked to lower asthma...
Breastfeeding is widely recognized for its nutritional and immunological benefits, yet its lasting influence on asthma and allergy development in...
OM-85 add-on therapy improves control in T2-high a...
Adults with difficult-to-treat T2-high asthma who experience frequent flare-ups may benefit from add-on treatment with the bacterial lysate OM-85...
